产品编号：GM-60247AB
产品名称：Anti-MMAE Mouse IgG1 Antibody (11C10E3)
目录价：询价
产品编号：GM-60247AB
产品名称：Anti-MMAE Mouse IgG1 Antibody (11C10E3)
目录价：询价
GM-60247AB-100 100μg
GM-60247AB-1000 1mg
Target Monomethyl auristatin E
Antibody Type Monoclonal
lsotype Mouse IgG1
Clone 11C10E3
Expression System CHO
Aggregation /
Purity >95% as determined by SDS-PAGE
Endotoxin /
Sterility 0.2 μm Filtered
Antigen /
Conjugate Unconjugated
Application ELISA, PK
Alternative Names /
Description Monomethyl auristatin E (MMAE) is a synthetic antineoplastic agent. Because of its toxicity, it cannot be used as a drug itself; instead, it is linked to a monoclonal antibody (MAB) which directs it to the cancer cells. In International Nonproprietary Names for MMAE-MAB-conjugates, the name vedotin refers to MMAE plus its linking structure to the antibody. It is a potent antimitotic drug derived from peptides occurring in marine shell-less mollusc Dolabella auricularia called dolastatins which show potent activity in preclinical studies, both in vitro and in vivo, against a range of lymphomas, leukemia and solid tumors. Monomethyl auristatin E is an antimitotic agent which inhibits cell division by blocking the polymerisation of tubulin. The linker to the monoclonal antibody is stable in extracellular fluid but is cleaved by cathepsin once the conjugate has entered a tumor cell, thus activating the antimitotic mechanism.
Formulation Dulbecco's phosphate-buffered solution, pH 7.4.
产品编号：GM-60247AB
产品名称：Anti-MMAE Mouse IgG1 Antibody (11C10E3)
目录价：询价
产品编号：GM-60247AB
产品名称：Anti-MMAE Mouse IgG1 Antibody (11C10E3)
目录价：询价
GM-60247AB-100 100μg
GM-60247AB-1000 1mg
GM-60247AB-100 100μg
GM-60247AB-1000 1mg
Target Monomethyl auristatin E
Antibody Type Monoclonal
lsotype Mouse IgG1
Clone 11C10E3
Expression System CHO
Aggregation /
Purity >95% as determined by SDS-PAGE
Endotoxin /
Sterility 0.2 μm Filtered
Antigen /
Conjugate Unconjugated
Application ELISA, PK
Alternative Names /
Description Monomethyl auristatin E (MMAE) is a synthetic antineoplastic agent. Because of its toxicity, it cannot be used as a drug itself; instead, it is linked to a monoclonal antibody (MAB) which directs it to the cancer cells. In International Nonproprietary Names for MMAE-MAB-conjugates, the name vedotin refers to MMAE plus its linking structure to the antibody. It is a potent antimitotic drug derived from peptides occurring in marine shell-less mollusc Dolabella auricularia called dolastatins which show potent activity in preclinical studies, both in vitro and in vivo, against a range of lymphomas, leukemia and solid tumors. Monomethyl auristatin E is an antimitotic agent which inhibits cell division by blocking the polymerisation of tubulin. The linker to the monoclonal antibody is stable in extracellular fluid but is cleaved by cathepsin once the conjugate has entered a tumor cell, thus activating the antimitotic mechanism.
Formulation Dulbecco's phosphate-buffered solution, pH 7.4.
Target Monomethyl auristatin E
Antibody Type Monoclonal
lsotype Mouse IgG1
Clone 11C10E3
Expression System CHO
Aggregation /
Purity >95% as determined by SDS-PAGE
Endotoxin /
Sterility 0.2 μm Filtered
Antigen /
Conjugate Unconjugated
Application ELISA, PK
Alternative Names /
Description Monomethyl auristatin E (MMAE) is a synthetic antineoplastic agent. Because of its toxicity, it cannot be used as a drug itself; instead, it is linked to a monoclonal antibody (MAB) which directs it to the cancer cells. In International Nonproprietary Names for MMAE-MAB-conjugates, the name vedotin refers to MMAE plus its linking structure to the antibody. It is a potent antimitotic drug derived from peptides occurring in marine shell-less mollusc Dolabella auricularia called dolastatins which show potent activity in preclinical studies, both in vitro and in vivo, against a range of lymphomas, leukemia and solid tumors. Monomethyl auristatin E is an antimitotic agent which inhibits cell division by blocking the polymerisation of tubulin. The linker to the monoclonal antibody is stable in extracellular fluid but is cleaved by cathepsin once the conjugate has entered a tumor cell, thus activating the antimitotic mechanism.
Formulation Dulbecco's phosphate-buffered solution, pH 7.4.
